Renovis


Evotec is a life science company pioneering the future of drug discovery and preclinical development. They aim for technology and science leadership, accelerating the journey from concept to cure through cutting-edge technology, disruptive science, and extensive disease knowledge. Their expertise spans from small molecules to biotherapeutics, with a focus on scientific excellence, deep disease understanding, and proprietary next-gen technology platforms. Through Just – Evotec Biologics, they have revolutionized biologics design, development, and manufacturing, making high-quality therapies more accessible and affordable. Their fully integrated R&D value chain and flexible partnering models deliver speed, efficiency, and quality to ensure better treatments reach patients sooner.

Industries

biotechnology
health-care
pharmaceutical
therapeutics

Nr. of Employees

Very Large (1000+)


Patents

Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases

US-10472341-B2

View Details

Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases

US-8859545-B2

View Details

Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and dysfunctions

US-7745451-B2

View Details

Products

Pan-omics data platform / molecular patient databases

Platforms and curated molecular patient datasets for multi-omics analysis and translational research.

iPSC discovery / cell therapy platform

iPSC-derived cellular platforms for disease modelling, screening and development of cell therapies.

Resource hub of scientific content (Science Pool)

Curated technical resources, posters, webinars and method descriptions supporting scientific reproducibility and knowledge transfer.


Services

Integrated target ID, hit discovery, lead optimisation and preclinical development offered as CRO services.

Process development, cell line development, and clinical- to commercial-stage GMP manufacturing for biotherapeutics.

In vitro ADME and toxicology testing to support candidate selection and preclinical safety evaluation.

Monoclonal antibody optimisation and establishment of production cell lines to support biologics pipelines.

Multi-omics data integration and curated molecular patient databases to support translational research and target validation.

iPSC-based disease modelling, screening and cell therapy development services.

View All Services

Expertise Areas

  • Drug discovery and preclinical development
  • Biologics development and GMP manufacturing
  • ADME-Tox and safety assessment
  • Pan-omics integration and biomarker discovery
  • Show More (7)

Key Technologies

  • Induced pluripotent stem cells (iPSC)
  • CRISPR-based genetic screening
  • Proteomics
  • Metabolomics
  • Show More (6)

News & Updates

Aug 17 - 22, 2025, Vienna, Austria

Aug 26, 2025, San Francisco, CA, USA

Aug 29 - Sep 01, 2025, Madrid, Spain

Aug 31 - Sep 04, 2025, Porto, Portugal


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.